'Sars-cov-2 Antibodies' - 13 News Result(s)
- Science | Press Trust of India | Wednesday March 2, 2022Antibodies produced by two-doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study.
www.ndtv.com
- World News | Press Trust of India | Wednesday February 16, 2022Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
www.ndtv.com
- India News | Asian News International | Wednesday December 29, 2021During a recent study, an international team of scientists identified antibodies that neutralise Omicron and other SARS-CoV-2 variants.
www.ndtv.com
- Edited by Gadgets 360 Newsdesk | Saturday August 28, 2021Molecular Biology Consortium based at Berkeley Lab's Advanced Light Source (ALS) claims to have discovered an antibody that can neutralise all known SARS-CoV-2 strains, including the new mutants.
www.gadgets360.com
- World News | Press Trust of India | Monday August 23, 2021Researchers have identified an antibody that is highly protective at low doses against a wide range of variants of the SARS-CoV-2 virus which causes COVID-19.
www.ndtv.com
- World News | Press Trust of India | Wednesday August 18, 2021The Delta variant of the SARS-CoV-2 virus, that causes COVID-19, is unable to evade the antibodies generated by vaccination, according to a lab study.
www.ndtv.com
- Science | Press Trust of India | Friday August 6, 2021The levels of IgG antibodies against SARS-CoV-2 remain stable, or even increase, seven months after infection, according to a study of healthcare workers published in the journal Nature Communications on Friday.
www.ndtv.com
- Tamil Nadu News | Press Trust of India | Saturday July 31, 2021The third Tamil Nadu Cross Sectional Sero survey in July, covering over 26,000 samples revealed that at least 66.2 percent of the population has developed antibodies to SARS-CoV-2, the virus which causes COVID-19.
www.ndtv.com
- India News | Press Trust of India | Wednesday July 21, 2021The government on Tuesday said a serosurvey has found that two-thirds of the population - aged above six years - has SARS-CoV-2 antibodies but stressed that around 40 crore people are still vulnerable to the infection.
www.ndtv.com
- World News | Press Trust of India | Monday July 19, 2021Antibody levels remain high nine months after infection with SARS-CoV-2, the virus that causes COVID-19, whether symptomatic or asymptomatic, according to a study published on Monday that analysed data from an entire Italian town.
www.ndtv.com
- Science | Press Trust of India | Wednesday July 14, 2021A single dose of the Sputnik V vaccine may be enough to elicit strong antibody response against SARS-CoV-2, the virus that causes COVID-19, in already infected people, according to a study.
www.ndtv.com
- Science | Press Trust of India | Wednesday June 16, 2021The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists say.
www.ndtv.com
- India News | Press Trust of India | Monday September 7, 2020The presence of antibodies indicates previous exposure to the SARS-CoV-2 virus but may not always translate into protection against the disease, say scientists, citing imponderables such as what kind of antibodies, how many and how long they last.
www.ndtv.com
'Sars-cov-2 Antibodies' - 6 Video Result(s)
'Sars-cov-2 Antibodies' - 13 News Result(s)
- Science | Press Trust of India | Wednesday March 2, 2022Antibodies produced by two-doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study.
www.ndtv.com
- World News | Press Trust of India | Wednesday February 16, 2022Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
www.ndtv.com
- India News | Asian News International | Wednesday December 29, 2021During a recent study, an international team of scientists identified antibodies that neutralise Omicron and other SARS-CoV-2 variants.
www.ndtv.com
- Edited by Gadgets 360 Newsdesk | Saturday August 28, 2021Molecular Biology Consortium based at Berkeley Lab's Advanced Light Source (ALS) claims to have discovered an antibody that can neutralise all known SARS-CoV-2 strains, including the new mutants.
www.gadgets360.com
- World News | Press Trust of India | Monday August 23, 2021Researchers have identified an antibody that is highly protective at low doses against a wide range of variants of the SARS-CoV-2 virus which causes COVID-19.
www.ndtv.com
- World News | Press Trust of India | Wednesday August 18, 2021The Delta variant of the SARS-CoV-2 virus, that causes COVID-19, is unable to evade the antibodies generated by vaccination, according to a lab study.
www.ndtv.com
- Science | Press Trust of India | Friday August 6, 2021The levels of IgG antibodies against SARS-CoV-2 remain stable, or even increase, seven months after infection, according to a study of healthcare workers published in the journal Nature Communications on Friday.
www.ndtv.com
- Tamil Nadu News | Press Trust of India | Saturday July 31, 2021The third Tamil Nadu Cross Sectional Sero survey in July, covering over 26,000 samples revealed that at least 66.2 percent of the population has developed antibodies to SARS-CoV-2, the virus which causes COVID-19.
www.ndtv.com
- India News | Press Trust of India | Wednesday July 21, 2021The government on Tuesday said a serosurvey has found that two-thirds of the population - aged above six years - has SARS-CoV-2 antibodies but stressed that around 40 crore people are still vulnerable to the infection.
www.ndtv.com
- World News | Press Trust of India | Monday July 19, 2021Antibody levels remain high nine months after infection with SARS-CoV-2, the virus that causes COVID-19, whether symptomatic or asymptomatic, according to a study published on Monday that analysed data from an entire Italian town.
www.ndtv.com
- Science | Press Trust of India | Wednesday July 14, 2021A single dose of the Sputnik V vaccine may be enough to elicit strong antibody response against SARS-CoV-2, the virus that causes COVID-19, in already infected people, according to a study.
www.ndtv.com
- Science | Press Trust of India | Wednesday June 16, 2021The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists say.
www.ndtv.com
- India News | Press Trust of India | Monday September 7, 2020The presence of antibodies indicates previous exposure to the SARS-CoV-2 virus but may not always translate into protection against the disease, say scientists, citing imponderables such as what kind of antibodies, how many and how long they last.
www.ndtv.com